Building this domain's report…
Global rank
AI visibility
SEO health
Visits
per month, estimated
Keywords
ranking in Google
Organic share
of all search traffic
LLMS.txt
lines AI engines can read
Loading…
Featured
Keywords & Content
Site & Competitors
Building this domain's report…
Global rank
AI visibility
SEO health
Visits
per month, estimated
Keywords
ranking in Google
Organic share
of all search traffic
LLMS.txt
lines AI engines can read
Global rank: Worldwide · 2026-08
#59,958
AI visibility: Grade A
84
SEO health: Latest audit
86
Visits
60.0K
per month, estimated
Keywords
626
ranking in Google
Organic share
99%
59.7K organic visits
LLMS.txt
Published
105 lines AI engines can read
You're seeing the free preview of tremfya.com
A snapshot of how tremfya.com performs in search and in AI answers — every number below is one we hold, not a guess.
What this company does
Tremfya is a prescription medication developed to target the IL-23 pathway and provide relief for people living with chronic inflammatory conditions. The treatment is administered through subcutaneous injections on a regular schedule after initial starter doses. Patients often see improvements in skin clearance and joint symptoms when using the therapy as directed by their physician. It is positioned as an option for…
Our read on the site
Significant improvements needed.
Month by month, how much search traffic this domain earns — how much of it is free, and whether it is winning or losing ground.
Monthly visits
60.0K
Latest estimate
Change
No monthly history yet
It starts building from the first scan
Organic visits
59.7K
99% of all traffic
Paid visits
Whether AI engines can read this brand, understand it, and cite it when someone asks about its category.
Grade A
Scored from this domain's own data — llms.txt, profile completeness, technical health, crawlability and structured data.
The file AI engines read to understand a business. This is what it currently tells them about this one.
Status
Published
AI engines can read it
Lines
105
In the file
Size
7.2K
Characters
Sections
12
The searches this domain already ranks for, and how much traffic they bring it.
Ranking keywords
626
Found in Google for this domain
Visits they bring
59.7K
Estimated organic visits a month
No ranked-keyword data cached for this domain yet.
Ranked Keywords pulls the full list on its first run.
How the site itself performs — speed, accessibility and the technical basics both search crawlers and AI crawlers depend on.
Overall
SEO
The websites this domain competes with for the same searches and the same AI answers.
The business behind the domain — what it does, where it is, and who runs it.
Tremfya is a prescription medication developed to target the IL-23 pathway and provide relief for people living with chronic inflammatory conditions. The treatment is administered through subcutaneous injections on a regular schedule after initial starter doses. Patients often see improvements in skin clearance and joint symptoms when using the therapy as directed by their physician. It is positioned as an option for…
Which markets this brand actually serves, and where the web links to it from.
We only measure visitor geography for domains whose analytics are connected to us. For everyone else this is read live from the web and shown as an estimate — never mixed in with the measured numbers.
No market breakdown available for this brand.
Measured. The country each linking site is hosted in — a real signal of which regions know this brand.
No backlink sample for this domain yet.
Backlink Analytics collects one on its first run.
Who vouches for this domain. Strong, varied links are still the clearest signal of authority — to search engines and to AI engines that cite sources.
We haven't run a backlink crawl for tremfya.com yet, so there are no link counts to show. Backlink Analytics builds the profile on its first run and it appears here after that.
—
links on file
Neighbours of #59,958 in our worldwide ranking — each with its own report.
You are looking at one domain. tremfya.com competes in a market, and the same numbers exist for everyone in it — including the sites AI engines recommend instead of yours. Amrut.ai reads all of them, so you can see who is winning, why, and what to change first.
Run the free scan on your site and get its AI visibility score, its gaps, and the exact next steps.
A brand name or a domain — the whole overview loads in seconds.
317
0.53% of its search traffic
99%
1%
We don't hold a month-by-month history for this domain yet.
The traffic dashboard builds one from the first scan onwards.
Present
7/8 core fields
85/100
robots ✗ · sitemap ✗
Detected
Fix these first
Updated Jun 4, 2026
# Tremfya Official Site ## About Tremfya is a prescription medication developed to target the IL-23 pathway and provide relief for people living with chronic inflammatory conditions. The treatment is administered through subcutaneous injections on a regular schedule after initial starter doses. Patients often see improvements in skin clearance and joint symptoms when using the therapy as directed by their physician. It is positioned as an option for those who have not responded well to other treatments or are looking for a different mechanism of action. Healthcare providers prescribe Tremfya after evaluating a patient's overall health profile and disease severity. The medication comes with support resources that help individuals navigate insurance, dosing reminders, and side effect management. Clinical studies have shown meaningful results in both skin and joint outcomes for appropriate candidates. The brand focuses on delivering consistent results while maintaining a safety profile that doctors can monitor. Access programs exist to assist eligible patients with affordability and ongoing treatment continuity. Education materials on the site explain how the therapy works at a cellular level without overwhelming medical jargon. Real-world use continues to inform updates shared with the medical community. The company behind the product invests in ongoing research to explore addit
Sections in the file
Areas of work
Keywords it claims
Technologies
None listed
Products it tells AI about
Audience it targets
Performance
Accessibility
Excellent
8 more recommendations, with the exact changes and the pages they apply to, are in the full report.
Patients with moderate to severe plaque psoriasis or psoriatic arthritis · Adults · Global
Company type
Private